Delstrigo
Active substance: doravirine, lamivudine, tenofovir disoproxil fumarate
doravirine, lamivudine, tenofovir disoproxil fumarate
Centralised EU authorisationActive
Marketing holder: Merck Sharp & Dohme B.V.
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Products containing doravirine in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 4 |
|
| US 4 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-b71b-7dac-8426-fda67f3ba3ce,01a120c5-d1ce-7962-8495-e24f0f9eb733;count=2 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a12093-8bbe-7af1-adec-048b8447890e,01a12095-9ba2-71fa-b0c4-0f76df233c69;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/004746
- Registration status
- Active
- ATC code
- J05AR
Sources
- product · EMA · EMEA/H/C/004746 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004746 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004746 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/004746 · Verified 2026-10-09
- ingredients.2 · EMA · EMEA/H/C/004746 · Verified 2026-10-09